CEN/TC 206
Registration number (WIID) | Project No. | Title | Status |
---|---|---|---|
68925 | LVS EN ISO 10993-23:2021 | Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021) | Standarts spēkā |
22089 | LVS EN ISO 10993-5:2009 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009) | Standarts spēkā |
33857 | LVS EN ISO 10993-7:2009 /AC:2010 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Technical Corrigendum 1 (ISO 10993-7:2008/Cor 1:2009) | Standarts spēkā |
9493 | LVS EN ISO 10993-7:2009 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2008) | Standarts spēkā |
60133 | EN ISO 10993-11:2018 | Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017) | Standarts spēkā |
25795 | EN ISO 22442-3:2007 | Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (ISO 22442-3:2007) | Standarts spēkā |
60725 | LVS EN ISO 10993-18:2020 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020) | Standarts spēkā |
65480 | LVS EN ISO 22442-1:2021 | Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management (ISO 22442-1:2020) | Standarts spēkā |
60722 | EN ISO 10993-9:2021 | Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019) | Standarts spēkā |
60721 | EN ISO 10993-1:2020 | Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-10) | Standarts spēkā |
Displaying 31-40 of 190 results.